Summary
Overview
Work History
Education
Skills
Languages
Timeline
Generic

NIKIE BECKNELL

Ada

Summary

Highly accomplished and adaptable strategy and business leader with nearly 20 years of successive leadership roles. Demonstrated expertise in developing and executing successful corporate and business strategies. Proven ability to drive organic and inorganic growth, while cultivating high-performance teams. Strategic mindset and passion for driving success.

Overview

19
19
years of professional experience

Work History

VICE PRESIDENT OF CORPORATE STRATEGY

ZIMMER BIOMET INC.
01.2023 - Current
  • Company Overview: The worldwide leader in the musculoskeletal device segment with annual sales exceeding $7.5 billion
  • Develop and implement Zimmer Biomet’s strategic roadmap to deliver Top Quartile Performance and portfolio transformation for Senior Leaders and the Board of Directors
  • Led the Annual Strategic Plan, in partnership with Corporate Finance, delivering cross-functionally aligned growth strategies and a leveraged P&L
  • Performed research to inform strategic decision-making including peer benchmarking of key financial performance metrics, portfolio transformation, and capital allocation strategies
  • Assisted Global Businesses with strategy creation, refining strategic choices of: 'Where to Play', 'How to Win,' and identifying critical capabilities required to execute
  • Built a corporate market and competitive intelligence function that delivers actionable insights to the Executive Leadership Team, informed by ongoing trend monitoring
  • Developed and executed M&A strategy to drive inorganic growth and portfolio transformation
  • Developed a strategic framework and research methodology to identify and diligence high growth adjacent and white space opportunities across multiple Med Tech end markets, resulting in a robust pipeline of $1B+ acquisition targets
  • Created M&A roadmaps to deliver continued growth in multiple new end markets, in close partnership with Business and Corporate Development teams
  • Performed comprehensive research on key value drivers such as customer perception, market access, competition, and channel to assess target attractiveness and inform M&A financial models for tuck-in and larger-scale acquisitions, including the acquisition of Paragon 28 ($1B valuation)
  • In partnership with private equity, developed a novel R&D funding model to accelerate new product innovation through outsourcing and eventual acquisition of a portfolio of R&D projects that will generate >$500M annual revenue
  • The worldwide leader in the musculoskeletal device segment with annual sales exceeding $7.5 billion
  • Cultivated strong relationships with key stakeholders, including customers, vendors, regulators, and community leaders to promote collaboration and long-term success.

SENIOR DIRECTOR OF CORPORATE STRATEGY

ZIMMER BIOMET INC.
01.2020 - 01.2023
  • Company Overview: The worldwide leader in the musculoskeletal device segment with annual sales exceeding $7.5 billion
  • Develop and implement Zimmer Biomet’s strategic roadmap to deliver Top Quartile Performance and portfolio transformation for Senior Leaders and the Board of Directors
  • Led the Annual Strategic Plan, in partnership with Corporate Finance, delivering cross-functionally aligned growth strategies and a leveraged P&L
  • Performed research to inform strategic decision-making including peer benchmarking of key financial performance metrics, portfolio transformation, and capital allocation strategies
  • Assisted Global Businesses with strategy creation, refining strategic choices of: 'Where to Play', 'How to Win,' and identifying critical capabilities required to execute
  • Built a corporate market and competitive intelligence function that delivers actionable insights to the Executive Leadership Team, informed by ongoing trend monitoring
  • Developed and executed M&A strategy to drive inorganic growth and portfolio transformation
  • Developed a strategic framework and research methodology to identify and diligence high growth adjacent and white space opportunities across multiple Med Tech end markets, resulting in a robust pipeline of $1B+ acquisition targets
  • Created M&A roadmaps to deliver continued growth in multiple new end markets, in close partnership with Business and Corporate Development teams
  • Performed comprehensive research on key value drivers such as customer perception, market access, competition, and channel to assess target attractiveness and inform M&A financial models for tuck-in and larger-scale acquisitions, including the acquisition of Paragon 28 ($1B valuation)
  • In partnership with private equity, developed a novel R&D funding model to accelerate new product innovation through outsourcing and eventual acquisition of a portfolio of R&D projects that will generate >$500M annual revenue
  • The worldwide leader in the musculoskeletal device segment with annual sales exceeding $7.5 billion
  • Cultivated a culture of innovation by promoting creative thinking and encouraging employees to take calculated risks in pursuit of solutions.

DIRECTOR OF STRATEGY AND INTEGRATION MANAGEMENT

ZIMMER BIOMET INC.
01.2018 - 01.2020
  • Company Overview: The worldwide leader in the musculoskeletal device segment with annual sales exceeding $7.5 billion
  • Built and led the Corporate Integration Management Office, guiding new acquisitions through diligence and integration
  • Developed a high performing team of Integration Program Managers
  • Developed and implemented enterprise-wide integration processes and governance mechanisms to drive on-time delivery of key strategic, financial, and operational commitments and ensure Senior Management awareness of integration progress
  • Collaborated across functions and with Business Development to perform diligence and integrate three acquisitions that performed above deal model expectations
  • The worldwide leader in the musculoskeletal device segment with annual sales exceeding $7.5 billion

DIRECTOR OF PRODUCT MANAGEMENT, HIP RECONSTRUCTION

ZIMMER BIOMET INC.
01.2016 - 01.2018
  • Company Overview: The worldwide leader in the musculoskeletal device segment with annual sales exceeding $7.5 billion
  • Responsible for global business strategy and execution for the $2B Hip Reconstruction Business, drove 100bps top-line improvement to return business to growth
  • Developed and drove execution of a five-year strategic roadmap that drove YOY growth through annual new product launches and optimized profitability through aggressive product lifecycle management resulting in a >50% reduction in portfolio size
  • Built a high performing team of 20 globally-located product managers, post-merger and through transition; Proactively adjusted organizational structure and talent to support strategy by creating two distinct functions that delivered: Upstream Marketing: Organic and inorganic growth strategies supported by robust financial models and voice of customer inputs, Best-in-class new product launches
  • Product Management Operations: A streamlined process for product lifecycle maintenance, with a focus on end-of-life product strategy and portfolio optimization
  • Developed healthy cross-functional relationships with business partners including SIOP, Regional Commercial partners, Finance, Regulatory and Clinical, and other orthopedic business units to ensure alignment, drive execution, and foster a collaborative working environment
  • Built and maintained relationships with global key opinion leaders within the industry
  • The worldwide leader in the musculoskeletal device segment with annual sales exceeding $7.5 billion
  • Cultivated a positive work environment that fostered employee engagement, increased retention rates, and boosted overall team morale.

ACQUISITION INTEGRATION MANAGER

BIOMET INC.
01.2014 - 01.2015
  • Company Overview: Leader in the musculoskeletal device segment with annual sales exceeding $3 billion; Acquired by Zimmer in 2015 to form Zimmer Biomet
  • Managed complex integration activities for the Biomet Orthopedics Hip business during the twelve-month acquisition by Zimmer Orthopedics
  • Collaborated with cross-company partners to develop a new organizational structure, set operating budgets, and build a high-performing global product marketing and development team
  • Developed and executed integration roadmaps, in conjunction with BCG Consulting, to manage implementation of organizational structure, internal and external communications, and cross-compatibility projects
  • Participated in integration planning with various Integration Managers and Senior Leadership to identify interdependencies, neutralize roadblocks, and ensure alignment
  • Leader in the musculoskeletal device segment with annual sales exceeding $3 billion; Acquired by Zimmer in 2015 to form Zimmer Biomet
  • Minimized integration risks through proactive risk management, contingency planning, and diligent issue resolution.

MARKETING MANAGER, HIP RECONSTRUCTION

BIOMET INC.
01.2014 - 01.2015
  • Company Overview: Leader in the musculoskeletal device segment with annual sales exceeding $3 billion; Acquired by Zimmer in 2015 to form Zimmer Biomet
  • Oversaw global product strategy, launch and lifecycle management for an $80 million portfolio of acetabular brands, including direct U.S
  • Commercial sales support from 2007 until 2011
  • Executed product growth, development, and lifecycle strategies including new product creation and launch, development of messaging and collaterals, development and delivery of internal and external product training, and commercialization support
  • Led the successful launch of 10+ product systems from product conception through development and commercialization, growing the portfolio to $XM in annual revenue while improving gross margin by 5-10%
  • Developed end-of-life plans for a $50 million family of products and implemented via cross-functional teams including SIOP, finance, and commercial partners
  • Drove growth of the Hip Reconstruction Business by conducting sales calls with high priority competitive accounts in partnership with U.S
  • Distributors
  • Leader in the musculoskeletal device segment with annual sales exceeding $3 billion; Acquired by Zimmer in 2015 to form Zimmer Biomet

ADJUNCT FACULTY, PRODUCT MANAGEMENT

GRACE COLLEGE
01.2013 - 01.2015
  • Co-developed and taught a senior-level product management curriculum for 20 college students with emphasis on core product management principles and expectations in a professional environment

SENIOR PRODUCT MANAGER, HIP RECONSTRUCTION

BIOMET INC.
01.2012 - 01.2014
  • Company Overview: Leader in the musculoskeletal device segment with annual sales exceeding $3 billion; Acquired by Zimmer in 2015 to form Zimmer Biomet
  • Oversaw global product strategy, launch and lifecycle management for an $80 million portfolio of acetabular brands, including direct U.S
  • Commercial sales support from 2007 until 2011
  • Executed product growth, development, and lifecycle strategies including new product creation and launch, development of messaging and collaterals, development and delivery of internal and external product training, and commercialization support
  • Led the successful launch of 10+ product systems from product conception through development and commercialization, growing the portfolio to $XM in annual revenue while improving gross margin by 5-10%
  • Developed end-of-life plans for a $50 million family of products and implemented via cross-functional teams including SIOP, finance, and commercial partners
  • Drove growth of the Hip Reconstruction Business by conducting sales calls with high priority competitive accounts in partnership with U.S
  • Distributors
  • Leader in the musculoskeletal device segment with annual sales exceeding $3 billion; Acquired by Zimmer in 2015 to form Zimmer Biomet

PROJECT MANAGER, HIP RECONSTRUCTION

BIOMET INC.
01.2011 - 01.2012
  • Company Overview: Leader in the musculoskeletal device segment with annual sales exceeding $3 billion; Acquired by Zimmer in 2015 to form Zimmer Biomet
  • Led cross-functional teams to develop and execute project plans for new development projects, including the first global development project for the Hip Reconstruction Business
  • Delivered on-time milestone completion and NPI gate clearance for the launch of three new product development projects by working collaboratively to identify roadblocks, mitigate risk, and drive execution
  • Leader in the musculoskeletal device segment with annual sales exceeding $3 billion; Acquired by Zimmer in 2015 to form Zimmer Biomet

PRODUCT MANAGER

BIOMET INC.
01.2009 - 01.2011
  • Company Overview: Leader in the musculoskeletal device segment with annual sales exceeding $3 billion; Acquired by Zimmer in 2015 to form Zimmer Biomet
  • Oversaw global product strategy, launch and lifecycle management for an $80 million portfolio of acetabular brands, including direct U.S
  • Commercial sales support from 2007 until 2011
  • Executed product growth, development, and lifecycle strategies including new product creation and launch, development of messaging and collaterals, development and delivery of internal and external product training, and commercialization support
  • Led the successful launch of 10+ product systems from product conception through development and commercialization, growing the portfolio to $XM in annual revenue while improving gross margin by 5-10%
  • Developed end-of-life plans for a $50 million family of products and implemented via cross-functional teams including SIOP, finance, and commercial partners
  • Drove growth of the Hip Reconstruction Business by conducting sales calls with high priority competitive accounts in partnership with U.S
  • Distributors
  • Leader in the musculoskeletal device segment with annual sales exceeding $3 billion; Acquired by Zimmer in 2015 to form Zimmer Biomet

ASSOCIATE PRODUCT MANAGER

BIOMET INC.
01.2007 - 01.2009
  • Company Overview: Leader in the musculoskeletal device segment with annual sales exceeding $3 billion; Acquired by Zimmer in 2015 to form Zimmer Biomet
  • Oversaw global product strategy, launch and lifecycle management for an $80 million portfolio of acetabular brands, including direct U.S
  • Commercial sales support from 2007 until 2011
  • Executed product growth, development, and lifecycle strategies including new product creation and launch, development of messaging and collaterals, development and delivery of internal and external product training, and commercialization support
  • Led the successful launch of 10+ product systems from product conception through development and commercialization, growing the portfolio to $XM in annual revenue while improving gross margin by 5-10%
  • Developed end-of-life plans for a $50 million family of products and implemented via cross-functional teams including SIOP, finance, and commercial partners
  • Drove growth of the Hip Reconstruction Business by conducting sales calls with high priority competitive accounts in partnership with U.S
  • Distributors
  • Leader in the musculoskeletal device segment with annual sales exceeding $3 billion; Acquired by Zimmer in 2015 to form Zimmer Biomet

MARKETING COMMUNICATIONS SPECIALIST, HIP RECONSTRUCTION

BIOMET INC.
01.2006 - 01.2007
  • Company Overview: Leader in the musculoskeletal device segment with annual sales exceeding $3 billion; Acquired by Zimmer in 2015 to form Zimmer Biomet
  • Developed marketing and communications messaging and collateral for the global hip business in conjunction with the product management team
  • Created product messaging and collateral for the launch of two technology platforms including brochures, advertising, sales representative training, customer education, and event promotion for print and digital marketing campaigns
  • Leader in the musculoskeletal device segment with annual sales exceeding $3 billion; Acquired by Zimmer in 2015 to form Zimmer Biomet

Education

MASTER OF BUSINESS ADMINISTRATION -

Ball State University
Muncie, IN
01.2011

BACHELOR OF JOURNALISM - ERNIE PYLE SCHOOL OF JOURNALISM, BUSINESS, GRAPHIC DESIGN, SPANISH

Indiana University
Bloomington, IN
01.2004

Skills

  • Corporate and Business Strategy Creation
  • New Market/White Space Landscaping
  • M&A Target Identification and Diligence
  • Acquisition Integration Management
  • Market and Competitive Intelligence
  • Project Management
  • Product Marketing and Launch Excellence
  • Product Lifecycle Management
  • Broad Stakeholder Relationship Management
  • Team Development
  • Executive and Board Communication

Languages

English
Native or Bilingual
Spanish
Limited Working

Timeline

VICE PRESIDENT OF CORPORATE STRATEGY

ZIMMER BIOMET INC.
01.2023 - Current

SENIOR DIRECTOR OF CORPORATE STRATEGY

ZIMMER BIOMET INC.
01.2020 - 01.2023

DIRECTOR OF STRATEGY AND INTEGRATION MANAGEMENT

ZIMMER BIOMET INC.
01.2018 - 01.2020

DIRECTOR OF PRODUCT MANAGEMENT, HIP RECONSTRUCTION

ZIMMER BIOMET INC.
01.2016 - 01.2018

ACQUISITION INTEGRATION MANAGER

BIOMET INC.
01.2014 - 01.2015

MARKETING MANAGER, HIP RECONSTRUCTION

BIOMET INC.
01.2014 - 01.2015

ADJUNCT FACULTY, PRODUCT MANAGEMENT

GRACE COLLEGE
01.2013 - 01.2015

SENIOR PRODUCT MANAGER, HIP RECONSTRUCTION

BIOMET INC.
01.2012 - 01.2014

PROJECT MANAGER, HIP RECONSTRUCTION

BIOMET INC.
01.2011 - 01.2012

PRODUCT MANAGER

BIOMET INC.
01.2009 - 01.2011

ASSOCIATE PRODUCT MANAGER

BIOMET INC.
01.2007 - 01.2009

MARKETING COMMUNICATIONS SPECIALIST, HIP RECONSTRUCTION

BIOMET INC.
01.2006 - 01.2007

MASTER OF BUSINESS ADMINISTRATION -

Ball State University

BACHELOR OF JOURNALISM - ERNIE PYLE SCHOOL OF JOURNALISM, BUSINESS, GRAPHIC DESIGN, SPANISH

Indiana University
NIKIE BECKNELL